Aqx-1125 200 mg    (DrugBank: AQX-1125)

1 disease
IDDisease name (Link within this page)Number of trials
226Interstitial cystitis with Hunners ulcer1

226. Interstitial cystitis with Hunners ulcer    [ 133 clinical trials,   151 drugs,   (DrugBank: 46 drugs),   48 drug target genes,   137 drug target pathways]
Searched query = "Interstitial cystitis with Hunners ulcer", "Interstitial cystitis"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
1 / 133 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT02858453
(ClinicalTrials.gov)
July 201619/4/2016Efficacy and Safety of 2 Doses of AQX-1125 in Subjects With Interstitial Cystitis / Bladder Pain SyndromeThe LEADERSHIP 301 Trial: A 12-Week, Randomized, Multi-Center, Double-Blind, Placebo-Controlled, 3-Arm, Parallel-Group, Phase 3 Trial to Evaluate the Efficacy and Safety of 2 Doses of AQX-1125 Targeting the Src Homology 2-containing Inositol-5'-Phosphatase 1 (SHIP1) Pathway in Subjects With Interstitial Cystitis/Bladder Pain Syndrome Followed by an Extension PeriodInterstitial Cystitis;Bladder Pain Syndrome;Painful Bladder Syndrome;Chronic Interstitial CystitisDrug: AQX-1125 100 mg;Drug: AQX-1125 200 mg;Drug: PlaceboAquinox Pharmaceuticals (Canada) Inc.NULLUnknown status18 Years80 YearsAll433Phase 3United States;Belgium;Canada;Czechia;Denmark;Hungary;Latvia;Netherlands;Poland;Romania;Spain;United Kingdom;Czech Republic